{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:58:09Z","timestamp":1781096289846,"version":"3.54.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Female Pelvic Med Reconstr Surg"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To provide the rationale and design for a randomized, double-blind clinical trial of conjugated estrogen vaginal cream (applied for at least 5 weeks preoperatively and continued twice-weekly through 12 months postoperatively) compared with placebo in postmenopausal women with symptomatic pelvic organ prolapse undergoing a standardized transvaginal native tissue apical repair.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Study population, randomization process, study cream intervention, masking of participants and evaluators, placebo cream manufacture, standardized surgical intervention, and collection of adverse events are described. The primary outcome of surgical success is a composite of objectively no prolapse beyond the hymen and the vaginal cuff descending no more than one third the vaginal length; subjectively, no sense of vaginal pressure or bulging; and no retreatment for prolapse at 12 months. Time-to-failure postoperatively will be compared in the 2 groups with continued surveillance to 36 months. Secondary outcomes assessed at baseline, preoperatively (ie, after at least 5 weeks of study cream), and postoperatively at 6 month intervals include validated condition-specific and general quality-of-life metrics, overall impression of improvement, sexual function, vaginal atrophy symptoms, and body image. Challenges unique to this study include design and manufacture of placebo and defining and measuring study drug adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Recruitment of 204 women is complete with 197 randomized. There have been 174 surgeries completed with 15 more pending; 111 have completed their 12 month postoperative visit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This trial will contribute evidence-based information regarding the effect of perioperative vaginal estrogen as an adjunct therapy to standardized transvaginal native tissue prolapse surgical repair.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/spv.0000000000000899","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T22:38:24Z","timestamp":1592174304000},"page":"e227-e233","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Design of a Randomized Clinical Trial of Perioperative Vaginal Estrogen Versus Placebo With Transvaginal Native Tissue Apical Prolapse Repair (Investigation to Minimize Prolapse Recurrence of the Vagina using Estrogen: IMPROVE)"],"prefix":"10.1097","volume":"27","author":[{"given":"David D.","family":"Rahn","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly E.","family":"Richter","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Alabama, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Alpert Medical School of Brown University\/Women and Infants Hospital of Rhode Island, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma I.","family":"Larsen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Baylor Scott and White Memorial Hospital, Temple TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Hynan","sequence":"additional","affiliation":[{"name":"Departments of Population and Data Sciences and Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2 Pt 1","key":"bib1-20260610","first-page":"367","article-title":"Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"bib2-20260610","first-page":"CD012376","article-title":"Surgery for women with apical vaginal prolapse","volume":"10","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"19","key":"bib3-20260610","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1001\/jama.2013.4919","article-title":"Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse","volume":"309","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"bib4-20260610","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ajog.2003.08.040","article-title":"Impact of menopause on collagen subtypes in the arcus tendineous fasciae pelvis","volume":"190","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"bib5-20260610","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mob.2002.124845","article-title":"Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor","volume":"187","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"bib6-20260610","first-page":"CD007063","article-title":"Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"bib7-20260610","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9378(96)70243-0","article-title":"The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction","volume":"175","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"39","key":"bib8-20260610","first-page":"15","article-title":"Incontinence. Pelvic floor re-education","volume":"4","year":"1991","journal-title":"Nursing (Lond)"},{"issue":"1","key":"bib9-20260610","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/SPV.0b013e318278cc40","article-title":"Histologic and cytologic effects of vaginal estrogen in women with pelvic organ prolapse: a randomized controlled trial","volume":"19","year":"2013","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"bib10-20260610","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1210\/jc.2014-1216","article-title":"Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"bib11-20260610","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1447-0756.2001.tb01266.x","article-title":"The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study","volume":"27","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"bib12-20260610","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cct.2008.12.001","article-title":"Operations and pelvic muscle training in the management of apical support loss (OPTIMAL) trial: design and methods","volume":"30","year":"2009","journal-title":"Contemp Clin Trials"},{"issue":"10","key":"bib13-20260610","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jama.2014.1719","article-title":"Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial","volume":"311","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"bib14-20260610","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)","volume":"193","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"bib15-20260610","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00192-012-2020-8","article-title":"A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse\/Incontinence Sexual Questionnaire, IUGA-revised (PISQ-IR)","volume":"24","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"1","key":"bib16-20260610","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"1","key":"bib17-20260610","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mob.2003.379","article-title":"Validation of two global impression questionnaires for incontinence","volume":"189","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"bib18-20260610","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1191\/1740774504cn049oa","article-title":"The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA","volume":"1","year":"2004","journal-title":"Clin Trials"},{"issue":"4","key":"bib19-20260610","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/gme.0b013e3181a48c4e","article-title":"Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally","volume":"16","year":"2009","journal-title":"Menopause"},{"issue":"1","key":"bib20-20260610","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00192-014-2464-0","article-title":"Assessment of vaginal atrophy: a review","volume":"26","year":"2015","journal-title":"Int Urogynecol J"},{"issue":"1","key":"bib21-20260610","first-page":"45","article-title":"Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women","volume":"10","year":"2003","journal-title":"Menopause"},{"issue":"21","key":"bib22-20260610","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.296.21.joc60162","article-title":"Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial","volume":"296","year":"2006","journal-title":"JAMA"},{"key":"bib23-20260610","first-page":"133","article-title":"Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy","volume":"5","year":"2013","journal-title":"Int J Womens Health"},{"issue":"4","key":"bib24-20260610","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/SPV.0b013e31825e6401","article-title":"A randomized clinical trial of the impact of local estrogen on postoperative tissue quality after vaginal reconstructive surgery","volume":"18","year":"2012","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"bib25-20260610","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2013.10.011","article-title":"Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action","volume":"142","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"bib26-20260610","first-page":"518","article-title":"Proposed classification of complications of surgery with examples of utility in cholecystectomy","volume":"111","year":"1992","journal-title":"Surgery"},{"issue":"6","key":"bib27-20260610","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","article-title":"Vaginal estrogen for genitourinary syndrome of menopause: a systematic review","volume":"124","year":"2014","journal-title":"Obstet Gynecol"}],"container-title":["Female Pelvic Medicine &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPV.0000000000000899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:02:59Z","timestamp":1781092979000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPV.0000000000000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/spv.0000000000000899","relation":{},"ISSN":["2151-8378","2154-4212"],"issn-type":[{"value":"2151-8378","type":"print"},{"value":"2154-4212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}